Actively Recruiting
VICIS - Vienna Cirrhosis Study
Led by Medical University of Vienna · Updated on 2025-09-25
10000
Participants Needed
1
Research Sites
569 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Patients with advanced chronic liver diseases treated at the Vienna General Hospital of the Medical University of Vienna will be offered to participate in this prospective observational trial - including an optional participation in a biobank. Clinical parameters and laboratory parameters will be recorded for all patients and patients will undergo a regular follow-up schedule with clinical visits at the Vienna General Hospital. This study is linked to a biobank with serum/plasma, ascitic fluid, urine, GI tract mucosal biopsies, liver biopsies and stool collected from the study participants.
CONDITIONS
Official Title
VICIS - Vienna Cirrhosis Study
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age >18 years and <100 years
- Diagnosis of advanced chronic liver disease by liver stiffness 910kPa, HVPG >5mmHg, or histology F3/F4
- Written informed consent provided
You will not qualify if you...
- Withdrawal of written informed consent
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Medical University of Vienna
Vienna, Austria, 1090
Actively Recruiting
Research Team
T
Thomas Reiberger, M.D.
CONTACT
M
Mattias Mandorer, M.D.
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here